126 related articles for article (PubMed ID: 15620146)
1. [Detection of the activity of MMP2 and MMP9 in middle ear cholesteatoma].
Wang H; Xu Z; Tang A; Su J
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Oct; 18(10):620-2. PubMed ID: 15620146
[TBL] [Abstract][Full Text] [Related]
2. Gelatinolytic activity of matrix metalloproteinases 2 and 9 in middle ear cholesteatoma.
Suchozebrska-Jesionek D; Szymański M; Kurzepa J; Gołabek W; Stryjecka-Zimmer M
J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):628-32. PubMed ID: 19128667
[TBL] [Abstract][Full Text] [Related]
3. [Detection and correlation of lipopolysaccharide, vitamin D receptor and matrix metalloproteinase-9 in the middle ear cholesteatoma].
Li Y; Xu Z; Zhang L; Quan C; Lin X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Aug; 26(16):739-41, 746. PubMed ID: 23213753
[TBL] [Abstract][Full Text] [Related]
4. [The significance of keratinocyte in hyperproliferation of middle ear cholesteatoma].
Zhu Z; Hong Y; Wang Y; He G; Ye S
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jan; 30(2):139-43. PubMed ID: 27192911
[TBL] [Abstract][Full Text] [Related]
5. [Study on the expression and clinical significance of MMP9 and MVD in the external auditory canal and middle ear squamous cell carcinoma].
Liu X; Wang W; Chen J; Chen C; Zhou J
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Apr; 25(7):303-6. PubMed ID: 21710717
[TBL] [Abstract][Full Text] [Related]
6. [Expression of matrix metalloproteinase-2,9 in cholesteatoma from different positions].
Wang J; Yu LS
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Jan; 44(1):44-8. PubMed ID: 19484988
[TBL] [Abstract][Full Text] [Related]
7. [Expression of matrix metalloproteinasa-2,9 in cholesteatoma and middle ear cancer].
Zhu W; Xie Y; Wang P
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Apr; 36(2):119-22. PubMed ID: 12761978
[TBL] [Abstract][Full Text] [Related]
8. Stromal expression of matrix metalloprotease-9 in middle ear cholesteatomas.
Shibosawa E; Tsutsumi K; Takakuwa T; Takahashi S
Am J Otol; 2000 Sep; 21(5):621-4. PubMed ID: 10993447
[TBL] [Abstract][Full Text] [Related]
9. Cell cycle inhibitory protein p27 in human middle ear cholesteatoma.
Kuczkowski J; Bakowska A; Pawelczyk T; Narozny W; Mikaszewski B
ORL J Otorhinolaryngol Relat Spec; 2006; 68(5):296-301. PubMed ID: 16825801
[TBL] [Abstract][Full Text] [Related]
10. [Reconstruction of the auditory canal wall with bone chips from the temporal squama--preliminary results].
Gehrking E; Wollenberg B; Frenzel H
Laryngorhinootologie; 2007 Jun; 86(6):436-42. PubMed ID: 17265389
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase-2 and matrix metalloproteinase-9 in cholesteatoma and deep meatal skin.
Banerjee AR; James R; Narula AA
Clin Otolaryngol Allied Sci; 1998 Aug; 23(4):345-7. PubMed ID: 9762497
[TBL] [Abstract][Full Text] [Related]
12. [Significance of activated matrix metalloproteinase 2 (MMP2) in progression of bladder transitional cell carcinoma].
Zhang XP; Zhou FJ; Shen PF; Zhou C; Wei JX
Ai Zheng; 2003 Jun; 22(6):637-9. PubMed ID: 12948424
[TBL] [Abstract][Full Text] [Related]
13. [Epithelium-stroma interaction in cholesteatoma of the middle ear].
Jacob R; Welkoborsky HJ; Mann W
Laryngorhinootologie; 2001 Jan; 80(1):11-7. PubMed ID: 11272241
[TBL] [Abstract][Full Text] [Related]
14. MMP/TIMP imbalance in amniotic fluid during PROM: an indirect support for endogenous pathway to membrane rupture.
Fortunato SJ; Menon R; Lombardi SJ
J Perinat Med; 1999; 27(5):362-8. PubMed ID: 10642956
[TBL] [Abstract][Full Text] [Related]
15. [The expression of matrix metalloproteinase-1 and interleukin-1-alpha messenger ribonucleic acid in human middle ear cholesteatoma].
Liu J; Lin G; Huang J; Jiang Z
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2002 Feb; 37(1):30-3. PubMed ID: 12768791
[TBL] [Abstract][Full Text] [Related]
16. [The expression and significance of human beta-defensin 2 in middle ear cholesteatoma epithelium].
Ren X; Cui P; Chen W; Xu M
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Apr; 19(7):313-4. PubMed ID: 16001900
[TBL] [Abstract][Full Text] [Related]
17. [A study on expression of tumor necrosis factor alpha in middle ear cholesteatoma and its effect on bone destruction].
Li Z; Li X; Liu G
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Feb; 15(2):66-7. PubMed ID: 12541866
[TBL] [Abstract][Full Text] [Related]
18. [Expression of transforming growth factor-beta 1 matrix metalloproteinase-1 and its inhibitor in human middle ear cholesteatoma].
Yang X; Li X; Ma M; Zhang L; Zhang Q; Wang J; Wang B
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2002 Apr; 37(2):121-3. PubMed ID: 12768723
[TBL] [Abstract][Full Text] [Related]
19. The imbalance of enzymatic antioxidants in cholesteatoma.
Eskiizmir G; Yuceturk AV; Onur E; Var A; Temiz P
Acta Otolaryngol; 2009 Nov; 129(11):1187-91. PubMed ID: 19863309
[TBL] [Abstract][Full Text] [Related]
20. The effect of BMP-2, BMP-4 and BMP-6 on bone destruction of cholesteatoma presence.
Oger M; Alpay HC; Orhan I; Onalan EE; Yanilmaz M; Sapmaz E
Am J Otolaryngol; 2013; 34(6):652-7. PubMed ID: 23927997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
